Caplyta (lumateperone) was approved for the treatment of schizophrenia in 2019 and for depressive episodes linked to bipolar I or bipolar II disorder (bipolar depression) in 2021. Caplyta can be ...

The FDA has approved these drugs to treat ADHD ... while 1 in 13 has coexisting bipolar disorder. Below are a few examples of other treatment options that may help with adult ADHD: Learn more ...

Effective treatments for people with serious depression who have not been helped by antidepressant medications have novel ...

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

Regulators have approved the drug as a treatment for weight loss, Type 2 diabetes and lowering the risk of heart attacks and ...

S, Clinical Rater with BioBehavioral Research of Austin (BBRA) stopped by Studio 512 to talk about what BBRA does, and her ...

A brain rhythm working in tandem with the body's natural sleep-wake cycle may explain why bipolar patients alternate between ...

We are TRICARE-approved, with expertise and ... with diagnoses including depression, bipolar disorder, anxiety, PTSD, ADHD and who use drugs or alcohol. This service is currently offered at ...

Study published in Nature identifies nearly 300 genomic regions associated with bipolar disorder, and 36 key genes involved in the disease.

People with bipolar disorder may be at a higher risk of developing premenstrual dysphoric disorder (PMDD), but neither condition directly causes the other.

The FDA has approved a supplemental new drug application for Spravato, an esketamine nasal spray that can be used as ...